|
Comparison of first-line resistance levels in Beijing compared to non-Beijing strains (n = 709^) |
|||||||
| Drug |
Beijing strain (n = 361) |
Non-Beijing strain (n = 348) |
OR (95%CI) |
RR (95%CI) |
RD (95%CI) |
||
|
|
|||||||
| N resistant |
% resistant (95%CI) |
N resistant |
% resistant (95%CI) |
||||
|
|
|||||||
| Isoniazid* |
170 |
47.1 (48.0–52.3) |
53 |
15.2 (11.7–19.3) |
5.0 (3.5–7.1) |
3.1 (2.4–4.1) |
31.9 (25.2–38.5) |
| Rifampicin* |
140 |
38.8 (33.9–43.9) |
41 |
11.8 (8.7–15.5) |
4.7 (3.2–7.0) |
3.3 (2.4–4.5) |
27.0 (20.7–33.3) |
| MDR TB* |
127 |
35.2 (30.4–40.2) |
33 |
9.5 (6.7–12.9) |
5.2 (3.4–7.9) |
3.7 (2.6–5.3) |
25.7 (19.6–31.8) |
| Streptomycin* |
144 |
39.9 (34.9–45.0) |
45 |
12.9 (9.7–16.8) |
4.5 (3.1–6.5) |
3.1 (2.3–4.2) |
27.0 (20.5–33.4) |
| Ethambutol* |
89 |
24.7 (20.4–29.3) |
26 |
7.5 (5.0–10.6) |
4.1 (2.5–6.5) |
3.3 (2.2–5.0) |
17.2 (11.7–22.) |
|
* statistically significant difference at p < 0.001 ^ both epidemiological and drug resistance results were available for 709/1042 (68.0%) cultures; 31 cultures were non viable or contaminated; cultures were drawn from all dispensaries and prison facilities in Samara City. | |||||||
Balabanova et al. Respiratory Research 2006 7:44 doi:10.1186/1465-9921-7-44 |
|||||||